328
Table 19.1 (continued)
c
International Agency for Research on Cancer Classification Monographs Volume 1–111 updated 18 February 2015 (1 carcinogenic to humans, 2A
probably
carcinogenic to humans, 2B
possibly carcinogenic to humans, 3
not classifiable as carcinogenic to humans, n.c.
not classified)
d
EPA carcinogenic classification: A
human carcinogenic, B1 and B2
probable human carcinogenic, C
possible human carcinogenic, D
not classifiable as to
human carcinogenicity, E
evidence of non-carcinogenicity for humans
e
Estimation using BioHCwin software v1.01 on EPI Suite software developed by [94]
f
[95]
n.d.
not determined, n.c.
not classified
Various physical and chemical properties along with carcinogenic efficacy based on the comparison of toxic equivalent relative factor (TEF) with benzo[a]pyrene,
the most common isoform of benzopyrene which forms carcinogenic and mutagenic metabolites
A. Khan et al.
Table 19.1 (continued)
c
International Agency for Research on Cancer Classification Monographs Volume 1–111 updated 18 February 2015 (1 carcinogenic to humans, 2A
probably
carcinogenic to humans, 2B
possibly carcinogenic to humans, 3
not classifiable as carcinogenic to humans, n.c.
not classified)
d
EPA carcinogenic classification: A
human carcinogenic, B1 and B2
probable human carcinogenic, C
possible human carcinogenic, D
not classifiable as to
human carcinogenicity, E
evidence of non-carcinogenicity for humans
e
Estimation using BioHCwin software v1.01 on EPI Suite software developed by [94]
f
[95]
n.d.
not determined, n.c.
not classified
Various physical and chemical properties along with carcinogenic efficacy based on the comparison of toxic equivalent relative factor (TEF) with benzo[a]pyrene,
the most common isoform of benzopyrene which forms carcinogenic and mutagenic metabolites
A. Khan et al.